DOCGO INC (DCGO) Stock Fundamental Analysis

NASDAQ:DCGO • US2560861096

0.7535 USD
+0.01 (+1.09%)
Last: Feb 17, 2026, 10:12 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to DCGO. DCGO was compared to 102 industry peers in the Health Care Providers & Services industry. DCGO has a great financial health rating, but its profitability evaluates not so good. DCGO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • DCGO had negative earnings in the past year.
  • In the past year DCGO had a positive cash flow from operations.
  • DCGO had positive earnings in 4 of the past 5 years.
  • In multiple years DCGO reported negative operating cash flow during the last 5 years.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • The Return On Assets of DCGO (-14.58%) is worse than 79.41% of its industry peers.
  • The Return On Equity of DCGO (-19.07%) is worse than 65.69% of its industry peers.
Industry RankSector Rank
ROA -14.58%
ROE -19.07%
ROIC N/A
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • In the last couple of years the Profit Margin of DCGO has declined.
  • DCGO's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 31.21%, DCGO is in the better half of the industry, outperforming 60.78% of the companies in the same industry.
  • DCGO's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.21%
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DCGO has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for DCGO is higher compared to a year ago.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 1.17, we must say that DCGO is in the distress zone and has some risk of bankruptcy.
  • DCGO has a Altman-Z score of 1.17. This is in the lower half of the industry: DCGO underperforms 63.73% of its industry peers.
  • DCGO has a debt to FCF ratio of 0.32. This is a very positive value and a sign of high solvency as it would only need 0.32 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.32, DCGO belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that DCGO is not too dependend on debt financing.
  • DCGO has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. DCGO outperforms 80.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.32
Altman-Z 1.17
ROIC/WACCN/A
WACC8.13%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • DCGO has a Current Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.59, DCGO belongs to the best of the industry, outperforming 81.37% of the companies in the same industry.
  • DCGO has a Quick Ratio of 2.59. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.59, DCGO belongs to the top of the industry, outperforming 81.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.59
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -194.14%.
  • DCGO shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.93% yearly.
  • DCGO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -47.03%.
  • The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%

3.2 Future

  • The Earnings Per Share is expected to decrease by -42.21% on average over the next years. This is quite bad
  • DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -20.20% yearly.
EPS Next Y-311.85%
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.42
EV/EBITDA N/A
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • DCGO's earnings are expected to decrease with -42.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • DCGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DOCGO INC

NASDAQ:DCGO (2/17/2026, 10:12:34 AM)

0.7535

+0.01 (+1.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-10
Earnings (Next)02-25
Inst Owners50.6%
Inst Owner Change-7.44%
Ins Owners9.01%
Ins Owner Change14.71%
Market Cap73.70M
Revenue(TTM)368.09M
Net Income(TTM)-51.59M
Analysts78.33
Price Target2.55 (238.42%)
Short Float %6.53%
Short Ratio7.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.06%
Min EPS beat(2)-14.37%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-85.28%
Min EPS beat(4)-311.74%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-44.96%
EPS beat(12)4
Avg EPS beat(12)-60.37%
EPS beat(16)7
Avg EPS beat(16)32.87%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-4.25%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)1.64%
Revenue beat(8)3
Avg Revenue beat(8)-2.27%
Revenue beat(12)6
Avg Revenue beat(12)0.87%
Revenue beat(16)10
Avg Revenue beat(16)15.35%
PT rev (1m)-9.09%
PT rev (3m)-18.7%
EPS NQ rev (1m)1.25%
EPS NQ rev (3m)-24.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF 1.42
P/OCF 1.27
P/B 0.27
P/tB 0.35
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)0.53
FCFY70.33%
OCF(TTM)0.59
OCFY78.43%
SpS3.76
BVpS2.77
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.58%
ROE -19.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.21%
FCFM 14.08%
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score4
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.32
Debt/EBITDA N/A
Cap/Depr 39.73%
Cap/Sales 1.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.59
Altman-Z 1.17
F-Score4
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.14%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-326%
EPS Next Y-311.85%
EPS Next 2Y-83.02%
EPS Next 3Y-42.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.03%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-48.94%
Revenue Next Year-49.19%
Revenue Next 2Y-31.73%
Revenue Next 3Y-20.2%
Revenue Next 5YN/A
EBIT growth 1Y-223.09%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-161.07%
EBIT Next 3Y-28.18%
EBIT Next 5YN/A
FCF growth 1Y168.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.23%
OCF growth 3YN/A
OCF growth 5YN/A

DOCGO INC / DCGO FAQ

What is the fundamental rating for DCGO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DCGO.


What is the valuation status of DOCGO INC (DCGO) stock?

ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.


How profitable is DOCGO INC (DCGO) stock?

DOCGO INC (DCGO) has a profitability rating of 2 / 10.


What is the financial health of DOCGO INC (DCGO) stock?

The financial health rating of DOCGO INC (DCGO) is 7 / 10.